{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[13,2,13,3],[17,2,17,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910456911803321"]
[null,null,"Autore",null,"Sadock Benjamin J. <1933->"]
[null,null,"Titolo",null,"Kaplan & Sadock's pocket handbook of psychiatric drug treatment / / Benjamin J. Sadock, Virginia A. Sadock, Norman Sussman"]
[null,null,"Pubbl/distr/stampa",null,"Philadelphia : , : Wolters Kluwer, , 2005"]
[{"$nulls":4},"©2006, : Lippincott Williams & Wilkins"]
[null,null,"ISBN",null,"1-4511-6812-8"]
[null,null,"Edizione",null,"[Fourth edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (317 p.)"]
[null,null,"Disciplina",null,"616.89/18"]
[null,null,"Soggetti",null,"Psychopharmacology"]
[{"$nulls":4},"Psychotropic drugs"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"Calcium Channel Inhibitors\"\"\"\"Carbamazepine and Oxcarbazepine\"\"; \"\"Cholinesterase Inhibitors and Memantine\"\"; \"\"Dantrolene\"\"; \"\"Disulfiram and Acamprosate\"\"; \"\"Dopamine Receptor Agonists and Precursors: Apomorphine, Bromocriptine, Levodopa, Pergolide, Pramipexole, and Ropinirole\"\"; \"\"Dopamine Receptor Antagonists: Typical Antipsychotics\"\"; \"\"Lamotrigine\"\"; \"\"Lithium\"\"; \"\"Mirtazapine\"\"; \"\"Monoamine Oxidase Inhibitors\"\"; \"\"Nefazodone\"\"; \"\"Opioid Receptor Agonists: Methadone, Buprenorphine, and Levomethadyl\"\"; \"\"Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone\"\""]
[{"$nulls":4},"\"\"Phosphodiesterase-5 Inhibitors\"\"\"\"Selective Serotoninâ€?Norepinephrine Reuptake Inhibitors: Venlafaxine and Duloxetine\"\"; \"\"Selective Serotonin Reuptake Inhibitors\"\"; \"\"Serotoninâ€?Dopamine Antagonists: Atypical Antipsychotics\"\"; \"\"Sympathomimetics and Related Drugs\"\"; \"\"Thyroid Hormones\"\"; \"\"Trazodone\"\"; \"\"Tricyclics and Tetracyclics\"\"; \"\"Valproate\"\"; \"\"Yohimbine\"\"; \"\"Psychoactive Herbs\"\"; \"\"Intoxication and Overdose\"\"; \"\"Index\"\"; \"\"About the Authors\"\""]